The Latest Breaking News from Novavax

A whale with a lot of money to spend has taken a noticeably bearish stance on Novavax. Looking at options history for Novavax (NASDAQ:NVAX) we detected 23 strange trades.

Australians aged 18 and over can now get Novavax as their first and second vaccine for COVID-19. Officials are hoping that the protein-based formula will provide the "extra push" some may need to get the jab.

South Korea will begin offering Novavax Inc.’s COVID-19 vaccine at hospitals, nursing homes and public health centers next week, adding another tool to fight a fast-developing omicron surge

Face coverings still required in indoor public spaces in Spain; UK records 66,638 daily infections and 206 Covid-linked deaths

A whale with a lot of money to spend has taken a noticeably bearish stance on Novavax. Looking at options history for Novavax (NASDAQ:NVAX) we detected 11 strange trades.

Novavax Inc. (NASDAQ: NVAX) shares are trading lower Tuesday after the company acknowledged to Reuters that it has completed delivery of only about 10 million doses of its COVID

Novavax, Inc. (NASDAQ: NVAX) shares are tumbling Tuesday on a negative headline concerning the Maryland-based biopharma's COVID-19 vaccine.

Novavax Inc has delivered just a small fraction of the 2 billion COVID-19 shots it plans to send around the world in 2022 and has delayed first-quarter shipments in Europe and lower income countries such as the Philippines, public officials involved in their government's vaccine rollouts told Reuters.

The first shipment of Novavax touches down in Australia ahead of the rollout later this month, but there are a few more steps involved before it gets to vaccine clinics.